Latest Breaking News On - Lilly diabetes - Page 1 : comparemela.com

Eli Lilly Exec Says Seeing Out of Pocket Payments for Obesity Drug in US

Eli Lilly exec says seeing out of pocket payments for obesity drug in US

Eli Lilly exec expects obesity pill data in April 2025

Eli Lilly exec expects obesity pill data in April 2025

Data from Eli Lilly s late stage trial on experimental obesity pill orforglipron is expected in April 2025, a top Eli Lilly executive said on Monday. The pill is part of a class of drugs.

Eli Lilly exec says seeing out of pocket payments for obesity drug in US

Patrik Jonsson, President of Lilly Diabetes and Obesity, speaking at a Goldman Sachs healthcare conference, said a mid-single digit percentage of patients paid the full list price out of pocket for Zepbound in the first quarter of 2024 in the U.S., which compares to the low single digits for Mounjaro.